The TME of EGFR-mutated NSCLC is characterized by a highly immunosuppressive and complex network of cells, cytokines, and signaling pathways that hinder effective antitumor immune responses (Figure 4) [5,66]. Here, EGFR is linked to non-small cell lung carcinoma.